Mobile Menu - OpenMobile Menu - Closed

Quigley Calls for Designation of May As National Brain Tumor Awareness Month

May 29, 2020
Press Release

U.S. Representative Mike Quigley introduced a resolution calling for the month of May to be designated as National Brain Tumor Awareness Month. Brain tumors are the leading cause of death from cancer in children, and nearly 18,000 American lives were claimed last year alone. Recognizing May as National Brain Tumor Awareness Month increases awareness around the devastating diagnosis and honors those who have battled brain tumors. Increased recognition, coupled with strong federal funding, could lead to breakthroughs in treating and diagnosing brain tumors.

“I’m proud to once again introduce this important resolution, to build awareness and to honor those we’ve lost all too soon to the scourge of brain cancer,” said Quigley. “During National Brain Tumor Awareness Month, we aim to increase awareness and honor the memories of everyone who has been faced with this disease. This resolution is my promise to every family who has lost someone and to every American who receives this frightening diagnosis that Congress will not rest in our fight for better treatments and to one day find a cure.”

Quigley’s resolution urges for collaborative public-private approach to brain tumor research be utilized as the best means of advancing knowledge of and treatment of the disease.

The National Brain Tumor Society (NBTS) commended the introduction of the resolution as a positive step toward increasing public awareness.

"We are sincerely grateful for the continued leadership taken by Congressman Quigley, on this resolution and his overall efforts to ensure brain tumors continue to receive federal research dollars used to help discover cures," said David Arons, Chief Executive Officer, National Brain Tumor Society. "The estimated 87,000 Americans who will receive a brain tumor diagnosis in 2020 need to know that Congress is doing everything it can to support the development of better treatments to improve the quality of life and long-term prognosis of those individuals and families impacted by the disease.”